Message aux signatairesNovartis | Reduce $2.1M price of Life-Saving Drug, Zolgensma, for Spinal Muscular Atrophy!
Poland, Argentina and Brazil Joined Zolgensma Reimbursement Program!

Evely S.Denver, CO, États-Unis

19 juil. 2023
Although the treatment of Zolgensma was added with certain restrictions, this is a massive victory for hundreds of families in these countries. More information by country is provided below:
We believe that if Novartis provides a discounted price for the treatment, more countries will be able to cover Zolgensma to save babies lives.
Thank you for your support!
Soutenir maintenant
Signez cette pétition
Copier le lien
Facebook
WhatsApp
X
E-mail